» Articles » PMID: 37502021

Treatment Setting Among Individuals with Opioid Use and Criminal Legal Involvement, Housing Instability, or Medicaid Insurance, 2015-2021

Overview
Specialty Psychiatry
Date 2023 Jul 28
PMID 37502021
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Individuals with criminal legal involvement (CLI), housing instability, or Medicaid insurance may experience barriers accessing substance use treatment in certain settings. Previous research has found individuals in these groups are less likely to receive medications for opioid use disorder (MOUD), but the role treatment setting may play in low rates of MOUD is unclear.

Methods: We conducted a cross-sectional study using nationally representative survey data from 2015 to 2021. We estimated the proportion of individuals who had CLI, housing instability, or Medicaid insurance who received substance use treatment in a variety of settings. We used multivariable logistic regressions to estimate the associations between group and the receipt of MOUD across treatment settings.

Results: Individuals with CLI, housing instability, or Medicaid insurance were more likely to receive substance use treatment in hospitals, rehabilitation, and mental health facilities compared with individuals not in these groups. However, all groups accessed substance use treatment in doctors' offices at similar rates. Treatment at a doctor's office was associated with the highest likelihood of receiving MOUD (aOR 4.73 [95% CI: 2.2.15-10.43]). Across multiple treatment settings, Individuals with CLI or housing instability were less likely to receive MOUD.

Conclusions: Individuals with CLI, housing instability, or Medicaid insurance are more likely to access substance use treatment at locations associated with lower rates of MOUD use. MOUD access across treatment settings is needed to improve engagement and retention in treatment for patients experiencing structural disadvantage or who have low incomes.

Citing Articles

Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization.

Shearer R, Bart G, Beebe T, Virnig B, Shippee N, Winkelman T J Subst Use Addict Treat. 2024; 167:209505.

PMID: 39241929 PMC: 11527587. DOI: 10.1016/j.josat.2024.209505.

References
1.
Hartung D, Markwardt S, Johnston K, Geddes J, Baker R, Leichtling G . Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study. Addict Sci Clin Pract. 2022; 17(1):45. PMC: 9389731. DOI: 10.1186/s13722-022-00318-1. View

2.
Joudrey P, Khan M, Wang E, Scheidell J, Edelman E, McInnes D . A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019; 14(1):17. PMC: 6463640. DOI: 10.1186/s13722-019-0145-5. View

3.
Shearer R, Shippee N, Vickery K, Stevens M, Winkelman T . A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither - United States, 2006-2018. Lancet Reg Health Am. 2022; 7. PMC: 8979492. DOI: 10.1016/j.lana.2021.100174. View

4.
OBrien P, Stewart M, Shields M, White M, Dubenitz J, Dey J . Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field. Drug Alcohol Depend Rep. 2022; 4. PMC: 9495301. DOI: 10.1016/j.dadr.2022.100087. View

5.
Shavit S, Aminawung J, Birnbaum N, Greenberg S, Berthold T, Fishman A . Transitions Clinic Network: Challenges And Lessons In Primary Care For People Released From Prison. Health Aff (Millwood). 2017; 36(6):1006-1015. DOI: 10.1377/hlthaff.2017.0089. View